Tumor Suppressors in Lymphocytes
淋巴细胞中的肿瘤抑制因子
基本信息
- 批准号:7325816
- 负责人:
- 金额:$ 26.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-05 至 2009-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesAnchored Polymerase Chain ReactionAnimalsB-Cell LymphomasBreedingCellsChemicalsChromosome MappingDNADepthDiploidyDoseEthylnitrosoureaEventExposure toFemaleGenesGenetic Predisposition to DiseaseGenomeGenomicsGoalsGrowthHaploidyHaplotypesHereditary Malignant NeoplasmHumanInfectionInsertional MutagenesisLeadLymphocyteLymphomaMalignant NeoplasmsMurine leukemia virusMusMutagenesisMutateMutationMutation AnalysisNatureNeonatalOncogenesOrganismPartner in relationshipPathway interactionsPersonal SatisfactionPolymerase Chain ReactionPredispositionProto-OncogenesResearch PersonnelRetroviridaeSignal PathwaySignal TransductionSiteSuppressor GenesSuppressor-Effector T-LymphocytesTechniquesTimeTumor Suppressor GenesTumor Suppressor ProteinsTumor-Suppressor Gene InactivationViralViral Genomebasecell growthgenome sequencinglymphoid neoplasmmalesperm celltumortumorigenesis
项目摘要
Tumor suppressors in lymphocytes
The genes that are necessary for normal, controlled cell growth are called tumor suppressor genes, and
inactivation of these genes can lead to tumor formation. The majority of known tumor suppressors were
located by the genetic mapping of organisms with an inherited predisposition for cancer. However, familial
predisposition to cancer is responsible for only approximately 10% of human cancers and identificationof
tumor suppressors involved in non-familial cancers has been slower. The goal of this proposal is to define the
set of tumor suppressors that when deleted contributeto the formation of lymphocytetumors in mice; and
their interactions with protooncogenes, as completely as possible.
This will be attempted by retroviral insertionalmutagenesis, combined with chemical mutagenesis, to
inactivate both alleles in cells of a given mouse. The offspring of chemically mutagenized male mice are
subjected to insertional mutagenesis by retrovirus that induces tumors of lymphocyte origin. The viral
genome disrupts potential suppressor genes, leading to their inactivation, and at the same time creates a
marker for identifying the insertion loci. The tagged cancer genes will be cloned and sequenced by a high
throughput PCR based technique. Subsequently, a subset of them will be further characterized and the nature
of their cooperation with other oncogenes (co-mutations) will be determined.
淋巴细胞中的肿瘤抑制因子
正常、受控细胞生长所必需的基因称为肿瘤抑制基因,
这些基因的失活会导致肿瘤的形成。大多数已知的肿瘤抑制因子是
通过对具有遗传性癌症倾向的生物体进行基因图谱定位。然而,家族
癌症易感性仅导致约 10% 的人类癌症,并且识别
涉及非家族性癌症的肿瘤抑制因子的作用速度较慢。该提案的目标是定义
一组肿瘤抑制因子被删除后会导致小鼠淋巴细胞肿瘤的形成;和
它们与原癌基因的相互作用尽可能完全。
这将通过逆转录病毒插入诱变与化学诱变相结合来尝试,以
使给定小鼠细胞中的两个等位基因失活。经过化学诱变的雄性小鼠的后代是
通过逆转录病毒进行插入突变,诱导淋巴细胞来源的肿瘤。病毒式传播
基因组破坏潜在的抑制基因,导致其失活,同时产生
用于识别插入位点的标记。标记的癌症基因将通过高通量克隆和测序
基于通量PCR的技术。随后,其中的一个子集将被进一步表征,其性质
它们与其他癌基因的合作(共突变)将被确定。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pvt1-encoded microRNAs in oncogenesis.
- DOI:10.1186/1742-4690-5-4
- 发表时间:2008-01-14
- 期刊:
- 影响因子:3.3
- 作者:Beck-Engeser GB;Lum AM;Huppi K;Caplen NJ;Wang BB;Wabl M
- 通讯作者:Wabl M
Retroviral activation of the mir-106a microRNA cistron in T lymphoma.
- DOI:10.1186/1742-4690-4-5
- 发表时间:2007-01-25
- 期刊:
- 影响因子:3.3
- 作者:Lum AM;Wang BB;Li L;Channa N;Bartha G;Wabl M
- 通讯作者:Wabl M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATTHIAS R WABL其他文献
MATTHIAS R WABL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATTHIAS R WABL', 18)}}的其他基金
Peptides presented by DNA-specific B lymphocytes in lupus
狼疮中 DNA 特异性 B 淋巴细胞呈递的肽
- 批准号:
8930442 - 财政年份:2014
- 资助金额:
$ 26.59万 - 项目类别:
Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
- 批准号:
8088482 - 财政年份:2010
- 资助金额:
$ 26.59万 - 项目类别:
GENE TARGETED MICE WITH A SIMPLIFIED IMMUNE SYSTEM
具有简化免疫系统的基因靶向小鼠
- 批准号:
6373658 - 财政年份:1998
- 资助金额:
$ 26.59万 - 项目类别:
Gene Targeted Mice With A Simplified Immune System
具有简化免疫系统的基因靶向小鼠
- 批准号:
7406815 - 财政年份:1998
- 资助金额:
$ 26.59万 - 项目类别:
Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
- 批准号:
8465786 - 财政年份:1998
- 资助金额:
$ 26.59万 - 项目类别:
Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
- 批准号:
8278599 - 财政年份:1998
- 资助金额:
$ 26.59万 - 项目类别:
Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
- 批准号:
8663161 - 财政年份:1998
- 资助金额:
$ 26.59万 - 项目类别:
Gene Targeted Mice with a Simplified Immune System
具有简化免疫系统的基因靶向小鼠
- 批准号:
8077966 - 财政年份:1998
- 资助金额:
$ 26.59万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
玉米穗行数QTL克隆及优异等位基因型鉴定
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
GABRA2 genetic variants and chromosome conformation in induced pluripotent stem cell-derived neural cells
诱导多能干细胞衍生神经细胞中的 GABRA2 遗传变异和染色体构象
- 批准号:
10226053 - 财政年份:2018
- 资助金额:
$ 26.59万 - 项目类别:
GABRA2 genetic variants and chromosome conformation in induced pluripotent stem cell-derived neural cells
诱导多能干细胞衍生神经细胞中的 GABRA2 遗传变异和染色体构象
- 批准号:
10455631 - 财政年份:2018
- 资助金额:
$ 26.59万 - 项目类别:
GABRA2 genetic variants and chromosome conformation in induced pluripotent stem cell-derived neural cells
诱导多能干细胞衍生神经细胞中的 GABRA2 遗传变异和染色体构象
- 批准号:
9976412 - 财政年份:2018
- 资助金额:
$ 26.59万 - 项目类别: